Latest News from: UC Davis Comprehensive Cancer Center

Add to Favorites Subscribe Share
Go to Advanced Search

Showing results

11 of 1

Article ID: 687453

UC Davis Researcher Urges Caution on Engineered Stem Cells

UC Davis Comprehensive Cancer Center

In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse models.

3-Jan-2018 5:05 PM EST
Open in New Tab
Add to Favorites

Showing results

11 of 1

Chat now!